ASKP3 is a collaborative, interdisciplinary community led by experts committed to improving patient care through ketamine and other emerging treatments. The organization brings together professionals across various fields to share knowledge, promote ethical standards, and support responsible practices in psychedelic medicine.

ASKP3’s mission is to advance the treatment of both mental and physical health by establishing transparent, evidence-based standards for ketamine therapy. Through research, education, and the exchange of ideas, ASKP3 aims to elevate clinical care, encourage multidisciplinary collaboration, and increase awareness among the public, policymakers, and healthcare providers. The organization also embraces partnerships that help foster the development of other psychedelic therapies.